Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 07, 2019 07:47 ET | Source: Rich Pharmaceuticals

Rich Pharmaceuticals Reaches Agreement with Geopulse Exploration, Inc. (Cannco Brands)

LOS ANGELES, CA, Oct. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Rich Pharmaceuticals, Inc. (OTC PINK: RCHA) has agreed to be partially acquired by Geopulse Exploration, Inc. (OTC PINK: GPLS),...
April 10, 2018 07:00 ET | Source: Rich Pharmaceuticals

Rich Pharmaceuticals Explains How Targeted Immunotherapy Aids in the Treatment and Recovery of AML Patients

BEVERLY HILLS, CA , April 10, 2018 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC: RCHA), a Biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology,...
March 14, 2018 09:45 ET | Source: Rich Pharmaceuticals

Rich Pharmaceuticals' Study Drug RP-323 (TPA) is a Potential Therapeutic Agent for the Treatment of Hodgkin's Lymphoma

BEVERLY HILLS, CA , March 14, 2018 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC: RCHA), a Biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology,...
March 06, 2018 09:45 ET | Source: Rich Pharmaceuticals

Rich Pharmaceuticals' Study Drug RP-323 (TPA) Elevates White Blood Cells (WBCs) Which Play a Vital Role Fighting Infections, and in Immunotherapy

BEVERLY HILLS, CA, March 06, 2018 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC: RCHA), is a Biopharmaceutical Company focused on developing and commercializing innovative therapies in...
December 05, 2017 12:35 ET | Source: Rich Pharmaceuticals

UPDATE: Rich Pharmaceuticals Retains Experienced Contract Research Organization to Assist with Clinical Trials

BEVERLY HILLS, CA , Dec. 05, 2017 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC PINK: RCHA), a biopharmaceutical Company focused on developing and commercializing innovative therapies in...
December 05, 2017 10:35 ET | Source: Rich Pharmaceuticals

Rich Pharmaceuticals Retains Experienced Contact Research Organization to Assist with Clinical Trials

BEVERLY HILLS, CA , Dec. 05, 2017 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC PINK: RCHA), a biopharmaceutical Company focused on developing and commercializing innovative therapies in...